JPMorgan Downgrades Moderna (MRNA) to Neutral on Valuation Following 385% YTD Run-Up

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to JPMorgan Downgrades Moderna (MRNA) to Neutral on Valuation Following 385% YTD Run-Up

Moderna (MRNA) Trades Lower after Pfizer (PFE) and BioNTech (BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data

July 20, 2020 8:47 AM EDT

Moderna (NASDAQ: MRNA) Trades Lower after Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data

... More